F
$ Value
$5K
Shares
7,965
Price
$1
Filed
Feb 5
Insider
Name
Cummings James F.
Title
Chief Medical Officer
CIK
0001886760
Roles
Officer
Transaction Details
Transaction Date
2026-02-02
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
737,792
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2026. | This amount includes 75,618 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.
Filing Info
Cummings James F.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-28 | VXRT | F | $2K |
| 2026-03-24 | VXRT | F | $21K |
| 2026-03-18 | VXRT | F | $4K |
| 2026-03-16 | VXRT | A | $0 |
| 2026-03-16 | VXRT | A | $0 |
| 2026-02-02 | VXRT | F | $5K |
Other Insiders at VXRT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lo Steven
President, Chief Exec Officer
|
— | — | 2026-03-24 |
|
Tucker Sean
SVP, Chief Scientific Officer
|
— | — | 2026-03-28 |
|
Cummings James F.
Chief Medical Officer
|
— | — | 2026-03-28 |
|
Berg Edward B
SVP, General Counsel
|
— | — | 2026-03-24 |
|
Grasman Jeroen Nicolaas
Chief Financial Officer
|
— | — | 2026-03-16 |